The purpose of this study was to evaluate the penile vascular function by color Doppler ultrasonography (CDU) in patients with Peyronie's disease. A total of 136 men with Peyronie's disease were strati®ed according to their potency by history as Group I consisting of potent patients and Group II consisting of patients with erectile dysfunction. They were all evaluated by penile CDU.
Introduction
Peyronie's disease is characterized by ®brosis throughout the entire thickness of the tunica albuginea of the corpora cavernosa. Pain on erection, curvature and palpable plaque on the shaft of penis are the most common presenting symptoms. 1, 2 Although it was once considered a rare condition, 1 ± 2% incidence of symptomatic Peyronie's disease has been found in different populations of male physicians. 1,3 ± 5 The disease is most commonly seen in the men in their ®fties and affects approximately 10% of men with erectile dysfunction. 5, 6 Patients with Peyronie's disease do not have a common starting point but two discernable phases are usually noted during the progression of the disease. 1 The acute in¯ammatory phase usually lasts about 12 ± 18 months. Pain on erection and unstable deformity are the most common presenting symptoms during this phase. It is followed by the chronic or stable phase characterized by minimal pain, stable deformity and stable plaque size.
Sexual dysfunction, being a part of presenting symptoms, is reported to be 4 ± 80% among different series. 6 ± 8 Although the excessive angulation due to the curvature, painful erection, tenderness on the plaque and performance anxiety may all contribute to erectile dysfunction (ED), it has been shown that penile vascular abnormalities are responsible for ED in 61 ± 70% Peyronie's patients. 1,7 ± 12 Veno-occlusive dysfunction (VOD) is reported to be present in 30 ± 86% and the role of arterial disease has also been shown in 44 ± 52% Peyronie's patients with ED although it is not easy to determine the exact etiologic factor in every case. 7 ± 12 Furthermore patients with Peyronie's disease, presenting most commonly during the ®fth decade, may only re¯ect the conditions of potency of age matched patients without Peyronie's disease. 8 Erectile function and penile vascular status are key factors in deciding the treatment modality, since patients with preserved erectile function and adequate penile vascular system are considered candidates for reconstructive surgery; while those *Correspondence: A Kadi with severe vascular disease who do not respond to intracavernous injection (ICI) of vasoactive agent andaor vacuum erection device (VD) are assigned to implantation of penile prosthesis. 12 ± 14 The most cost-effective method of assessment of penile vascular system is thought to be color Doppler ultrasonography (CDU). 15 ± 17 Currently peak systolic velocity (PSV) is commonly used to diagnose arterial insuf®ciency, and end diastolic velocity (EDV) based criteria (such as the resistance index) are used to diagnose VOD. Assessment of penile arterial system with CDU has a sensivity of 100% and speci®city of 95% when compared to pudendal arteriography. 16, 17 Although dynamic infusion cavernosometry and cavernosography (DICC) is supposed to be the gold standard for detection of VOD, an EDV of b 5 cmasec measured after ICI of vasoactive agent by CDU, yielded a speci®city of 56% and sensitivity of 90% for detection of venous leakage when compared with DICC. 16, 17 Similarly, resistance index (RI)`75% by CDU is associated with venous leakage in 95% patients when compared with DICC. 16, 17 The subject of this study is to categorize Peyronie's patients according to their erectile status by history and de®ne the penile vascular abnormalities assessed by CDU among Peyronie's patients with or without ED.
Material and methods
During a 6-y period, 136 men with clinically established Peyronie's disease underwent penile vascular evaluation at our institution. The ®rst part of patient evaluation was directed toward a detailed medical and sexual history. Physical examination focused on abnormalities of the genitalia and the extent of the palpable induration on the penis. Patients were strati®ed into two groups according to their erectile status by history. Group 1 consisted of 40 (29.4%) patients with suf®cient rigidity for intercourse despite their penile deformities. Patients with consistent inability to attain and maintain a penile erection suf®cient to permit satisfactory sexual intercourse were considered as having ED (70.6%, n 96) and classi®ed as Group II. 18 The presence of risk factors for vascular diseases such as diabetes mellitus, hypertension, atherosclerosis and serum lipid abnormalities were recorded and their relation with erectile function and penile vascular status were investigated. 9 Once the acute phase resolved and the plaque matured, all patients underwent penile CDU examination (ATL, Ultramark 9) with a 10 MHz imaging frequency and 7 MHz Doppler frequency. 9, 15, 16 The study was performed with the patient in supine position. High-resolution ultrasound was used to measure the changes in the diameter of cavernous arteries in transverse projection in the proximal penile shaft. About 5 to 10 min after intracavernous injection of 10 mg prostaglandin E1 (ie corresponding to the initial ®lling phase of erection), the ®rst set of hemodynamic measurements were obtained. Color Doppler imaging was performed to display blood¯ow through the cavernosal arteries. Patients were then asked to perform manual genital selfstimulation in privacy, without ejaculation, for 10 min in order to induce maximal erection and to overcome sympathetic overactivity due to anxiety. 19 The second set of measurements were obtained at the end of manual genital self-stimulation (expecting to correspond to the rigid phase of erection) when patients stated that the erctile response was similar or better than they had at home. Recorded parameters included diameters of right and left cavernous arteries before and after intracavernous injection, peak systolic velocity (PSV), end diastolic velocity (EDV) and resistance index (RI) calculated as PSV ± EDVaPSV. In all cases the same operator (AK) conducted the CDU in the same manner in order to preclude inter-observer variability.
The cut-off value was b 35 cmasec for a normal PSV, values below were considered to be diagnostic penile arterial disease. 9, 19, 20 Cases with full erectile response to ICI and self-stimulation, almost always had an EDV`5 cmasec and were considered to have an intact veno-occlusive system. Diagnosis of VOD was concluded in patients with both EDV b 5 cmasec and RI`0.9. 16, 19, 20 Patients were considered as having mixed (arterial venous) vascular disease when there was evidence of both arterial insuf®ciency and VOD on CDU.
Statistical analysis was performed by w 2 test.
Results
Out of 136 patients with Peyronie's disease, 29.4% (n 40) were potent (mean age: 51.9 AE 10.5 y) while the remainders (70.6%; n 96) had ED (mean age: 55.2 AE 9.8 y) by history. There was no statistically signi®cant difference between the mean age and the duration of disease in both groups but these were slightly higher in Group II (Table 1) . At least one risk factor for vascular disease could be demonstrated in 80.1% patients. Hypercholesterolemia and diabetes mellitus type II (NIDDM) were the two most common risk factors. The prevalence of risk factors among men with ED (84.3%) was signi®cantly higher (P`0.05) than that of potent patients (70%) as shown on Table 1 .
Overall, 23.5% patients had normal penile vascular system by CDU (Table 2 ). VOD and arterial insuf®ciency was observed in 31.6% and 6.6% patients, respectively. The CDU ®ndings of the remainders (38.2%) revealed mixed (arterial venous) penile vascular disease (Table 2) .
In Group I, the prevalence of VOD was 40% while it was 28% in Group II (P b 0.05). No patient in Group I had pure arterial disease. However, 9.3% (n 9) cases with ED by history (Group II) had pure arterial disease although they achieved full erectile response (ie EDV`5 cmasec) after ICI combined with manual genital self-stimulation ( Table 2 ). The prevalence of mixed vascular disease in Group I and II was 10% and 50%, respectively. The prevalence of arterial disease and mixed vascular disease in Group II was signi®cantly (P`0.05) higher than that of Group I. However, there was no statistically signi®cant difference (P b 0.05) of VOD prevalence between groups.
CDU revealed normal penile vascular system in 12.5% patients with ED by history (Group II). However, 50% potent patients had penile vascular abnormalities, mainly slight VOD, as obtained by CDU ( Table 2 ). The presence of risk factors for vascular disease was signi®cantly higher (P`0.05) in patients with arterial insuf®ciency and mixed penile vascular disease.
Discussion
Despite the extensive clinical experience and prolonged period of time that has elapsed since its original description by Fallopius in 1561, a clear understanding of the etiology of ED and penile vascular abnormalities in patients with Peyronie's disease remains lacking. 2 The most widely accepted theory is that Peyronie's disease is caused by abnormal ®brotic reaction of the tunica albuginea to repetitive microtrauma to erect or¯accid penis with an inherent predisposition to exaggerated ®brotic response. 4, 6, 21 The ultimate rigidity during erection is generated by the tunica and its ®bers attached to intercorporeal septum and the cavernous ®brous skeleton, stretching to their limits of extensibility. 5 The ®brous scar tissue of Peyronie's disease restricts the expansion of the involved aspect of the penis during tumescence, and thereby causes the erection to be bent. However, it has been reported that the intracorporeal pressures measured in the proximal and distal portion of the plaque are the same. 5 Fibrotic changes of tunica also result in VOD by disturbing the anatomic relation between the emissary veins and tunica albuginea. Normally venules draining the corpora are passively compressed between the expanding corporeal tissue and the tunica albuginea. When Peyronie's disease is present, compliance of the underlying corporeal smooth musculature is decreased thus preventing venous compression. 22 Several reports have demonstrated venous leakage at the site of ®brotic plaque. A recent study has shown that decrease in elastic ®ber concentration and alteration of tunica albuginea contribute to ED by impairing the veno-occlusive function of the tunica albuginea. 23 Metz et al showed abnormal venous drainage in 69% of Peyronie's patients with ED using dynamic Xenon washout and stated that VOD was primarily responsible for ED. 24 Gasior et al reported their results of DICC in Peyronie's patients with ED and found that 86% had evidence of VOD. 25 However, Lopez and Jarow were the ®rst to show that the high prevalence of VOD was unique to Peyronie's disease. 8 In their study, the presence of VOD, assessed by CDU, among Peyronie's patients with ED was signi®cantly higher (59%) than that of age matched control population. 8 Although we did not have any age-matched control group, the prevalence of VOD in our series was 31.6%, which resembles previously reported series, except Levine and Coogan's (Table 3) . 9 We compared the prevalence of VOD, assessed by CDU, in Peyronie's patients with (Group II) or without (Group I) ED, in order to Table 2 ). In our series, 40% of patients in Group I had VOD. This group consisted of potent patients stating that they had suf®cient penile erection to permit satisfactory sexual intercourse at home but could not achieve full erection after ICI combined with manual genital self-stimulation. Their CDU studies revealed an EDV ! 5 cmasec and were diagnosed to have slight VOD. No additional diagnostic studies, such as Rigiscan, was performed in this group of patients since they actually did not have ED by history. A study by Mostbeck et al, has shown that there was a signi®cant decrease in RI, as an indicator venous insuf®ciency, with increasing heart rate suggesting that some internal and external factors effect the results obtained by CDU. 26 Furthermore, the high prevalence of smoking in our population might have an effect on the results. À subclinic period of ED' may also help to explain the high percentage (50%) of penile vascular disease among potent Peyronie's patients. But further longterm studies are needed to clarify this thesis. It is also important to obtain EDV measurements by CDU at the end of manual genital self-stimulation in privacy after ICI when the patient states that the erectile response is similar or better than he obtained at home. Additionally, a second or a third ICI (that is redosing) might have resulted in complete smooth muscle relaxation and reduced the high prevalence of VOD among potent cases. Although VOD has been claimed to be present in a high percent of Peyronie's patients with ED, the role of arterial disease has also been investigated. Different series with CDU reported that 29.5% to 52% patients had deterioration in cavernous arterial in¯ow as demonstrated by PSV,¯ow volume and acceleration values. 7 ± 12 However, the overall prevalence of pure arterial insuf®ciency in our series (6.6%) is signi®cantly less than that of other series (Table 3) . This difference may be explained by the criteria selected to de®ne the arterial or by the high prevalence of mixed vascular disease (38.2%) in our study. That is, we considered a PSV value greater than 35 cmasec, not 25 or 30 cmasec as proposed by other authors, 8, 15, 16 as diagnostic criteria for normal penile arterial system according to our own previous study on normal subjects. 19 Moreover, in a study on Peyronie's patients by Levine and Coogan, normal penile color duplex ultrasound parameters for cavernous arterial¯ow was considered to be PSV values b 35 cmasec. 9 Similarly, Chiou et al evaluated hemodynamic patterns of pharmacologically induced erection by CDU and concluded PSV values b 35 cmasec to be normal. 20 The type and the software of CDU device may also affect the hemodynamic parameters obtained.
Penile vascular disease seems to be responsible for ED in 87.5% Peyronie's patients, with the arterial insuf®ciency being the predominant pathology determining the erectile status. The prevalence of arterial disease, either as a single cause (9.3%) or concomitant with VOD (50%), was 59.3% in Group II, which consisted of Peyronie's patients with ED (Table 2) . On the contrary, only 10% of potent Peyronie's patients (Group I) had arterial insuf®-ciency component on CDU. In fact, these suboptimal PSV values obtained in potent cases may be considered as`functional arterial insuf®ciency' since this may be a result of excessive adrenergic tone associated with anxiety. These data con®rm the previous report by Levine and Coogan who stated that vascular insuf®ciency, particularly arterial disease, accounted for much of the diminished rigidity in men with Peyronie's disease. 9 Pure VOD, which is almost inevitable during the pathogenesis of Peyronie's disease, does not seem to affect the erectile function primarily since groups with or without ED had similar prevalence of pure VOD in our series. Neurogenic and psychogenic ED should also be considered in patients with Peyronie's disease since no vascular abnormality could be shown by CDU in 12.5% Peyronie's patients with ED (Table 2) .
Some authors have argued that the majority of Peyronie's patients with ED had other risk factors for impotence and concluded that ED associated with Peyronie's disease was not directly related to the disease process. 9 The presence of risk factors for vascular disease, which contribute directly to the arterial component of the penile vascular system, signi®cantly determine the erectile status of patients with Peyronie's disease. 3, 9 At least one risk factor for vascular disease could be identi®ed in 84% patients in Group II (Table 1 ) and hypercholesterolemia and diabetes mellitus type II (NIDDM) were the leading ones. We have also observed that patients without any identi®able risk factor, such as diabetes, Lopez and Jarow regarded that Peyronie's patients with ED had a signi®cantly longer duration of the disease. 8 The duration of the disease was slightly higher in patients with ED (Table 1) indicating that ED is inevitable during the process of the disease. Although aging can be regarded as an other etiologic risk factor for ED, we could not ®nd any statistically signi®cant difference between the ages of the groups (Table 1) , although it was also slightly higher in Group II.
We believe that penile CDU provides reliable information on both hemodynamic factors, arterial in¯ow and veno-occlusive mechanism, involved in ED and allows us to individualize therapeutic options. 27 Manual genital self-stimulation, combined with ICI, has shown to overcome sympathetic over-activity due to anxiety and reduce the occurrence of false negative results further increasing the diagnostic value of CDU. 19 This was con®rmed clinically by comparing the erections at home with those obtained after ICI in the of®ce in most cases.
Conclusion
Our results indicate that, 70.6% of Peyronie's patients complain of erectile dysfunction. Overall, penile vascular disease can be detected by penile CDU in 76.6%. However, the prevalence of penile vascular disease rises up to 87.5% in patients with ED (Group II), while it is 50% among potent patients. Arterial disease, either as a single cause (9.3%) or concomitant with VOD (50%), seems to be the predominant pathology determining the erectile status. The penile CDU provides reliable information on hemodynamic changes involved in ED, and allows us to individualize therapeutic options.
